The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 6, 2013, Pages 871-877

  Morgan, Todd M ^a   Barocas, Daniel A ^a   Chang, Sam S ^a   Phillips, Sharon E ^a   Salem, Shady ^a   Clark, Peter E ^a   Penson, David F ^a,b   Smith, Joseph A ^a   Cookson, Michael S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CYSTECTOMY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEMATOCRIT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA;

BLADDER CANCER; BLOOD; CYSTECTOMY; TRANSFUSION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CYSTECTOMY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84880698650     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.07.012     Document Type: Article

References (30)

1. Rawn J. The silent risks of blood transfusion. Curr Opin Anaesthesiol 2008, 21: 664-668.
2. Kleinman S., Caulfield T., Chan P., et al. Toward an understanding of transfusion-related acute lung injury: Statement of a consensus panel. Transfusion 2004, 44: 1774-1789.
3. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32: 39-52.
4. Hébert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340: 409-417.
5. Vincent J.L., Baron J.-F., Reinhart K., et al. Anemia and blood transfusion in critically ill patients. JAMA 2002, 288: 1499-1507.
6. Busch O.R., Hop W.C., Hoynck van Papendrecht M.A., et al. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993, 328: 1372-1376.
7. Ojima T., Iwahashi M., Nakamori M., et al. Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 2009, 13: 1821-1830.
8. Shiba H., Ishida Y., Wakiyama S., et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 2009, 13: 1636-1642.
9. Wang C.-C., Iyer S.G., Low J.K., et al. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2009, 16: 1832-1842.
10. Healthcare Cost and Utilization Project (HCUP) 2008, HCUP Databases, Agency for Healthcare Research and Quality, Rockville, MD, [cited; Available from: http://www.hcup-us.ahrq.gov/databases.jsp.
11. Harrell F.E. Regression Modeling Strategies, with Applications to Linear Models, Survival Analysis and Logistic Regression 2001, Springer, New York.
12. Amato A., Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006, CD005033 Accessed February 1, 2011.
13. Ford B.S., Sharma S., Rezaishiraz H., et al. Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 2008, 26: 364-367.
14. Gallina A., Briganti A., Chun F.K.-H., et al. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy. BJU Int 2007, 100: 1249-1253.
15. Paul R., Schmid R., Busch R., et al. Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology 2006, 67: 137-141.
16. McClinton S., Moffat L.E., Scott S., et al. Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 1990, 77: 140-142.
17. Moffat L.E., Sunderland G.T., Lamont D. Blood transfusion and survival following nephrectomy for carcinoma of kidney. Br J Urol 1987, 60: 316-319.
18. Jahnson S., Bergstrom R., Pedersen J. Extent of blood transfusion and cancer-related mortality after cystectomy and urinary diversion for bladder cancer. Br J Urol 1994, 74: 779-784.
19. Nieder A.M., Manoharan M., Yang Y., et al. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 2007, 69: 881-884.
20. Blumberg N., Heal J.M. Immunomodulation by blood transfusion: An evolving scientific and clinical challenge. Am J Med 1996, 101: 299-308.
21. Opelz G., Terasaki P.I. Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet 1974, 2: 696-698.
22. Williams J.G., Hughes L.E. Effect of perioperative blood transfusion on recurrence of Crohn's disease. Lancet 1989, 2: 131-133.
23. Blajchman M.A., Bardossy L., Carmen R., et al. Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993, 81: 1880-1882.
24. Upile T., Jerjes W., Mahil J., et al. Blood product transfusion and cancer prognosis. Clin Adv Hematol Oncol 2009, 7: 656-661.
25. Glance L.G., Dick A.W., Mukamel D.B., et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011, 114: 283-292.
26. Edna T.H., Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998, 41: 451-459.
27. Liewald F., Wirsching R.P., Zülke C., et al. Influence of blood transfusions on tumor recurrence and survival rate in colorectal carcinoma. Eur J Cancer 1990, 26: 327-335.
28. Hollenbeck B.K., Wei Y., Birkmeyer J.D. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology 2007, 69: 871-875.
29. Shabsigh A., Korets R., Vora K., et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009, 55: 164-176.
30. Bracey A.W., Radovancevic R., Riggs S.A., et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect on patient outcome. Transfusion 1999, 39: 1070-1077.